DUBBO, Australia–(BUSINESS WIRE)–Kraken Regen announces the launch of its Collagen Platform Technology, a high-purity, fibril-forming biomaterial engineered to support cutting-edge research in Regenerative Medicine with applications in 3D bioprinting and advanced cell culture systems.
Designed specifically for research use, Kraken Collagen Hydrogel delivers a biologically relevant environment that closely mimics the human extracellular matrix (ECM), improving the predictive power and reproducibility of in vitro models.
Current biomaterials often require complex preparation, rely on synthetic modification, or introduce variability that impacts reproducibility. Kraken Regen addresses these challenges by offering:
- An ultra-purified, naturally regenerative source of collagen, providing biologically relevant ECM environments that cells recognize and thrive in,
- Fibrillogenesis and biochemical cues, which accurately represent natural ECM mechanics, and
- Consistent batch performance with predictable, consistent gelation, offering improved printability and structural stability.
“Our team has developed a high-performance, natural collagen hydrogel for researchers who no longer need to make trade-offs between biological relevance, long-term stability, and printability. Supported with extensive benchmark testing, Kraken Collagen Hydrogel outperforms the market-leaders, offering excellent shape fidelity and stiffness that cells thrive in. We’ve achieved an optimum balance in our hydrogel formulation to be able to address the needs of the Regenerative Medicine research market” states Vanessa Worsfold, Head of Technology.
Applications Across Advanced Biosystems
Kraken Collagen Hydrogel is designed to support a wide range of research and pre-clinical testing applications, including:
- Extrusion-based 3D bioprinting solutions for precise fabrication of collagen-rich bioinks,
- Advanced 3D cell culture and ECM-mimetic assays enabling physiologically relevant in vitro modelling,
- Organoid development and maturation, facilitating cellular organisation, structural integrity, and functional performance,
- Tissue engineering and regenerative biology models, leveraging tuneable collagen matrices to recapitulate natural microenvironments,
- Robust preclinical model development, accelerating translational research and therapeutic pipelines, and
- Mechanobiology-focused platforms designed to uncover critical cell-matrix interactions and biomechanical responses.
Kraken Collagen Hydrogel is available in 5mL units at a concentration 18 mg/mL for Research Use Only (RUO). It is currently accessible to customers in the United States and Australia through direct online ordering at www.krakenregen.com, providing easy purchasing, and fast and secure delivery. Product availability in further countries is planned over the coming months.
About Kraken Regen
Kraken Regen is an incubated venture of Maverick Bio whose mission is to supply breakthrough technologies that support Regenerative Medicine research applications. Founded on a commitment to advancing scientific discoveries, Kraken Regen leverages decades of technical expertise and collaborations with academic partners to deliver solutions that improve efficiency, accuracy, and reproducibility in research workflows. Learn more at krakenregen.com and connect with us on LinkedIn.
Important Notice
Kraken Collagen Hydrogel is intended for research use only and not for clinical or therapeutic applications.
Contacts
Kraken Regen
Dimity Middleton
+ 61 2 6885 1200
